期刊文献+

原发性扩张型心肌病心肌灌注显像与心脏磁共振延迟增强成像的对比研究 被引量:9

Comparison of ^99Tc^m-MIBI myocardial perfusion imaging and delayed enhancement MRI for pa- tients with idiopathic dilated cardiomyopathy
原文传递
导出
摘要 目的对原发性扩张型心肌病(IDCM)患者进行静息MPI和心脏磁共振延迟增强成像(DE—MRI)的对比分析,探讨2种诊断方法不同图像特征之间的对应关系。方法40例确诊为IDCM的住院患者,均行99Tcm-MIBI静息MPI和DE-MRI,间隔不超过7d。静息心肌灌注图像分为2种特征:弥漫性放射性减低和节段性放射性减低或缺损;DE—MRI分为4种类型:(1)无延迟强化;(2)壁间延迟强化;(3)内膜下延迟强化;(4)透壁性延迟强化。两样本率的比较采用,检验。结果在40例患者的静息MPI中,心肌放射性分布呈弥漫性减低19例(47.5%),呈节段性减低或缺损21例(52.5%);两者DE-MRI延迟强化的发生率分别为26.3%(5/19)与85.7%(18/21),差异有统计学意义(X2=14.401,P〈0.001)。对18例节段性放射性异常和延迟强化的患者按心肌节段分析,灌注正常、灌注减低与灌注缺失3组DE—MRI分型构成分别为112:35:2:5,98:23:7:1,13:0:5:5,其中正常组与缺失组、减低组与缺失组之间差异有统计学意义(,值为29.183与25.110,P均〈0.001)。结论IDCM患者MPI既可以表现为典型的弥漫性放射性减低,也可表现为节段性放射性减低或缺损,后者DE—MRI出现延迟强化的比例较高。 Objective To compare 99Tcm-MIBI MPI with delayed enhancement MRI (DE-MRI) in patients with idiopathic dilated cardiomyopathy (IDCM), Methods Forty patients with IDCM were included. They underwent both rest 99Tcm-MIBI myocardial perfusion imaging and DE-MRI within 7 days. 99Tcm- MIBI MPI was performed to identify diffuse or segmental abnormal perfusion patterns including reduced or defect perfusion segments. DE-MRI images were divided into 4 categories: no delayed enhancement, septal, subendocardial and transmural delayed enhancement. χ2 test was used for data analysis. Results Diffuse and segmental perfusion abnormality on 99Tcm-MIBI MPI were found in 19 (47.5%) and 21 (52.5%) patients respectively, while DE-MRI enhancement was simultaneously found in 5 patients of the former (5/ 19, 26.3% ) and 18 (18/21, 85.7% ) of the latter (χ2 = 14.401, P〈0.001). For those (n = 18) with both segmental perfusion abnormality and DE-MRI enhancement, the number of segments of the 4 DE-MRI categories were 112: 35: 2: 5, 98: 23: 7: 1, and 13: 0: 5:5 for normal, reduced and defect perfusion segments respectively. A significant difference was found in the DE-MRI enhancement categories between normal and defect perfusion segments (χ2 = 29. 183, P 〈 0.001 ) and between reduced and defect peffusion segments as well (χ2 = 25.110, P 〈 0.001 ). Conclusions Both diffuse and segmental perfusion abnormalities on 99Tcm-MIBI MPI can be found in patients with IDCM. DE-MRI enhancement is more frequently found in patients with segmental perfusion abnormality.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2011年第4期245-249,共5页 Chinese Journal of Nuclear Medicine
关键词 心肌病 充血性 体层摄影术 发射型计算机 单光子 磁共振成像 MIBI Cardiomyopathy, congestive Tomography, emission-computed, single-photon Magnetic resonance imaging MIBI
  • 相关文献

参考文献19

  • 1田月琴,刘秀杰,史蓉芳,刘蕴忠,吴清文,张晓丽,党爱民,陈柯萍,张朝阳,乔树宾,吴元,吴维力.扩张性心肌病和缺血性心肌病心肌灌注、代谢及功能的综合评价[J].中华核医学杂志,2000,20(3):105-108. 被引量:8
  • 2Li LX, Nohara R, Okuda K, et al. Comparative study of ^201Tl- scintigraphic image and myocardial pathologic finding in patients with dilated cardiomyopathy. Ann Nucl Med, 1996, 10: 307-314.
  • 3Kloeke F J, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guide- lines for the clinical use of cardiac radionuclide imagingIexecutive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidlines (ACC/AHA/ ASNC Committee to Revise the 1995 Guidlines for the Clinical use of Cardiac Radionuclide Imaging). J Am Coll Cardiol, 2003, 42: 1318-1333.
  • 4Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med, 1994, 331 : 1564-1575.
  • 5Glamann DB, Lange RA, Corbett JR, et al. Utility of various radi- onuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. Arch Intern Med, 1992, 152: 769-772.
  • 6Wu YW, Yen RF, Chieng PU, et al. ^201Tl myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. J Nucl Cardiol, 2003, 10 : 369-374.
  • 7Gott|ieb I, Macedo R, Bluemke DA, et al. Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: cur- rent applications and future perspectives. Heart Fail Rev, 2006, 11 : 313-323.
  • 8Maron B J, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart As- sociation Scientific Statement from the Council on Clinical Cardiolo- gy, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epide- miology and Prevention. Circulation, 2006, 113: 1807-1516.
  • 9赵世华,闫朝武,杨敏福,陆敏杰,蒋世良,李世国,张岩,刘琼,刘玉清,何作祥.磁共振心肌灌注延迟增强与核素心肌灌注/代谢显像识别存活心肌对比研究[J].中华心血管病杂志,2006,34(12):1072-1076. 被引量:26
  • 10Wu YW, Tadamura E, Kanao S, etal. Myocardial viability by con- trast-enhanced cardiovascular magnetic resonance in patients with cor- onary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography. Int J Cardiovasc Imaging, 2007, 23: 757-765.

二级参考文献13

  • 1赵世华,陆敏杰,张岩,蒋世良,黄连军,王红宇,吴言伶,杜茉佳,刘玉清.1.5 T高端MR在心血管病诊断中的应用[J].中华放射学杂志,2005,39(6):577-581. 被引量:30
  • 2浦寿月.扩张型(充血性)原发性心肌病[J].中华内科杂志,1984,23:389-391.
  • 3浦寿月,中华内科杂志,1984年,23期,389页
  • 4Ghesani M,Depuey EG,Rozanski A.Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.Echocardiography,2005,22:165-177.
  • 5Berman DS,Hachamovitch R,Shaw LJ,et al.Roles of nuclear cardiology,cardiac computed tomography,and cardiac magnetic resonance:assessment of patients with suspected coronary artery disease.J Nucl Med,2006,47:74-82.
  • 6Kim RJ,Fieno DS,Parrish TB,et al.Relationship of MRI delayed contrast enhancement to irreversible injury,infarct age,and contractile function.Circulation,1999,100:1992-2002.
  • 7Chen EQ,MacIntyre WJ,Go RT,et al.Myocardial viability studies using fluorine-18-FDG SPECT:a comparison with fluorine-18-FDG PET.J Nucl Med,1997,38:582-586.
  • 8Kuhl HP,Beek AM,van der Weerdt AP,et al.Myocardial viability in chronic ischemic heart disease:comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.J Am Coll Cardiol,2003,41:1341-1348.
  • 9Klein C,Nekolla SG,Bengel FM,et al.Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging:comparison with positron emission tomography.Circulation,2002,105:162-167.
  • 10Klocke FJ,Baird MG,Lorell BH,et al.ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).Circulation,2003,108:1404-1418.

共引文献32

同被引文献223

  • 1陈刘婷,姜洪.心脏磁共振在心肌病中的应用进展[J].中华临床医师杂志(电子版),2012,6(16):4814-4815. 被引量:4
  • 2心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:552
  • 3Fatkin D, Otway R, Richmond Z. Genetics of dilated cardiomyop- athy. Heart Fail Clin, 2010, 6: 129-140.
  • 4Wexler RK, Elton T, Pleister A, et al. Cardiomyopathy: an over- view. Am Fam Physician, 2009 : 778-784.
  • 5Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet, 2010, 375 : 752-762.
  • 6Neglia D, L'Abbate A. Coronary microvascular dysfunction and id- iopathic dilated cardiomyopathy. Phannacol Rep, 2005,57 Suppl : 151-155.
  • 7West AM, Kramer CM. Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol, 2010, 35: 176-220.
  • 8de Jong RM, Tio RA, van der Harst P, et al. Ischemic patterns assessed by positron emission tomoaphy predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol, 2009, 16: 769-774.
  • 9Ono H, Funabashi N, Uehara M, et al. Comprehensive evaluation of characteristics of left ventricular myocardium in a subject with non-coronary arterial cardiac dysfunction through segment by seg- ment analysis using various diagnostic modalities. Int J Cardiol, 2010, 145: 95-100.
  • 10Maron BJ', Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Out- comes Research and Functional Genomics and Translational BiologyInterdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 2006, 113 : 1807-1816.

引证文献9

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部